Auxier Asset Management LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 33,115 shares of the financial services provider’s stock, valued at approximately $6,143,000.
Several other hedge funds have also bought and sold shares of MRSH. Numerai GP LLC boosted its holdings in Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after acquiring an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd boosted its holdings in Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after acquiring an additional 11,648 shares during the last quarter. Barclays PLC boosted its holdings in Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after acquiring an additional 647,987 shares during the last quarter. Sarasin & Partners LLP boosted its holdings in Marsh & McLennan Companies by 0.9% during the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after acquiring an additional 8,283 shares during the last quarter. Finally, Brown Brothers Harriman & Co. boosted its holdings in Marsh & McLennan Companies by 26.4% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock worth $27,444,000 after acquiring an additional 28,419 shares during the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Research Report on MRSH
Marsh & McLennan Companies Price Performance
Shares of NYSE:MRSH opened at $164.26 on Thursday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The stock has a market capitalization of $79.35 billion, a P/E ratio of 20.53, a P/E/G ratio of 2.43 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $220.32.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion for the quarter. The business’s quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
